Variable | Total (N = 215) | APF group (N = 41) | Non APF group (N = 174) | P value |
---|---|---|---|---|
Surgical approacha | 0.344 | |||
Retroperitoneal | 178 (82.8%) | 36 (87.8%) | 142 (81.6%) | |
Transperitoneal | 37 (17.2%) | 5 (12.2%) | 32 (18.4%) | |
Operative time (min)b | 130.7 ± 41.0 | 158.0 ± 38.3 | 124.2 ± 39.0 | < 0.001 |
Warm ischemia time (min)b | 14.3 ± 7.3 | 17.9 ± 7.2 | 13.5 ± 7.2 | 0.001 |
Estimated blood loss (ml)c | 50.0 (30.0, 100.0) | 80.0 (50.0, 150.0) | 50.0 (30.0, 80.0) | 0.003 |
Transfusiona | 7 (3.3%) | 3 (7.3%) | 4 (2.3%) | 0.254 |
Length of postoperative stay (days)c | 8.0 (7.0, 9.0) | 8.0 (7.0, 9.0) | 8.0 (7.0, 9.0) | 0.191 |
Postoperative complicationa | 68 (31.6%) | 12 (29.2%) | 56 (32.2%) | 0.746 |
Clavien-Dindo I–II | 64 (29.8%) | 11 (26.8%) | 53 (30.5%) | |
Clavien-Dindo III–IV | 4 (1.8%) | 1 (2.4%) | 3 (1.7%) | |
Surgical margina | 0.957 | |||
Positive | 5 (2.3%) | 1 (2.4%) | 4 (2.3%) | |
Negative | 210 (97.7%) | 40 (97.6%) | 170 (97.7%) | |
Renal capsule rupturea | 8 (3.7%) | 5 (12.2%) | 3 (1.7%) | 0.006 |